Tebipenem pivoxil

CAS : 161715-24-8

Ref. 3D-LGA71524

Informations sur le produit

• Nom: Tebipenem pivoxil
• Synonymes: 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, [4R-[4α,5β,6β(R*)]]-, 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (4R,5S,6S)-, L-084, Orapenem, Spr 994, Tebipenam Pivoxil, [(2,2-dimethylpropanoyl)oxy]methyl (4R,5S,6S)-3-{[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate

Description

Tebipenem pivoxil is a quinolone antibiotic that can be used to treat bacterial infections. It is a prodrug that is converted in vivo to the active form, tebipenem. Tebipenem pivoxil has been shown to be effective against a wide range of bacteria, including Gram-positive and Gram-negative strains, and it has low toxicity for mammalian cells. Tebipenem pivoxil binds to DNA gyrase, topoisomerase IV, and other enzymes within the bacterial cell's ribosome by competitive inhibition. This binding prevents the formation of an antibiotic-inhibitor complex with the enzyme cell wall synthesis that is required for cell wall biosynthesis, inhibiting protein synthesis and cell division. Tebipenem pivoxil has shown antimicrobial activity against a number of organisms, such as Staphylococcus aureus (MRSA), Enterobacteriaceae (E. coli),

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 497.63 g/mol
• Formule: C₂₂H₃₁N₃O₆S₂
• Degré de pureté: Min. 95%